Greco-Arab and Islamic Herbal-Derived Anticancer Modalities: From Tradition to Molecular Mechanisms by Zaid, Hilal et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 349040, 13 pages
doi:10.1155/2012/349040
Review Article
Greco-Araband IslamicHerbal-Derived AnticancerModalities:
From Tradition to Molecular Mechanisms
HilalZaid,1,2 MichaelSilbermann,3 EranBen-Arye,4,5 andBashar Saad1,2
1Qasemi Research Center, Al-Qasemi Academy, P.O. Box 124, Baqa El-Gharbia 30100, Israel
2Faculty of Arts and Sciences, Arab American University Jenin, P.O. Box 240, Jenin, Palestine
3Technion—Israel Institute of Technology, Middle East Cancer Consortium, Haifa, Israel
4Integrative Oncology Program, The Oncology Service, Lin Medical Center, Clalit Health Services,
Western Galilee District, Haifa, Israel
5Complementary and Traditional Medicine Unit, Department of Family Medicine, Faculty of Medicine,
Technion-Israel Institute of Technology, Haifa, Israel and Clalit Health Services, Western Galilee District, Haifa, Israel
Correspondence should be addressed to Bashar Saad, bsaad@netvision.net.il
Received 17 July 2011; Accepted 26 September 2011
Academic Editor: Fatma U. Aﬁﬁ
Copyright © 2012 Hilal Zaid et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The incidence of cancer is increasing in the developed countries and even more so in developing countries parallel to the increase
in life expectancy. In recent years, clinicians and researchers advocate the need to include supportive and palliative care since
the establishment of the diagnosis and throughout the duration of treatment, with the goal of improving patients’ quality
of life. This patient-centered approach in supportive care is also shared by various traditional and complementary medicine
approaches. Traditional Arab-Islamic medicine oﬀers a variety of therapeutic modalities that include herbal, nutritional, and
spiritual approaches. Physicians and scholars, such as Avicenna (980–1037), Rhazes (965–915), Al Zahrawi (936–1013), and Ibn al
Naﬁs (1218–1288) referred to cancer etiology in various medicinal texts and suggested both preventive and therapeutic remedies
to alleviate suﬀering. This review presents research data related to the anticancer activities of herbs used in Arab-Islamic medicine
and allude to their potential role in improving the quality of life of cancer patients.
1.Introduction
In recent years, traditional Arab-Islamic herbal medicine has
been gaining interest in the scientiﬁc community, and more
speciﬁcally, regarding cancer treatment [1–3]. This school of
medicine, often referred to as Greco-Arab medicine, is still
inﬂuential in Arab and Islamic societies, especially through-
out the Mediterranean region. Throughout Muslim history,
Greco-ArabandIslamicherbalmedicineweretheﬁrstchoice
of treatment for ailments involving infertility, epilepsy, can-
cer, psychosomatic troubles, and depression. Arab and Mus-
lim physicians were among the ﬁrst to use scientiﬁc methods
in the ﬁeld of medicine, including the introduction of quan-
tity measurements, animal testing, and clinical trials. Hos-
pitals in the Arab-Islamic world featured drug tests, drug
purity regulations, and competency tests for physicians. The
earliest known tests related to public health were carried out
by Rhazes (865–925), searching for the most hygienic place
to build a hospital. To that purpose, he placed pieces of
meat throughout Baghdad and subsequently built a hospital
at the site where the meat decomposition was the least. In
his Comprehensive Book of Medicine,R h a z e sd o c u m e n t e dh i s
own clinical cases and provided very useful documentation
of various diseases. He also introduced urinalysis and stool
tests. Avicenna (980–1037), who introduced quantity mea-
surements in experimental medicine, discovered the con-
tagious nature of diseases, introduced clinical trials, risk
factor analysis, and the idea of a syndrome in the diagnosis
ofcomplexclinicalentities.Hisbook,TheCanonofMedicine,
was the ﬁrst to deal with evidence-based medicine, random-
ized controlled trials, and eﬃcacy tests.
Concerning medical documentation, the ﬁrst document-
ed evidence for a peer review publication was published by
Ishaq bin Ali al-Rahwi (854–931). In his work, the Ethics
of the Physician, he stated that a physician must always2 Evidence-Based Complementary and Alternative Medicine
document in duplicate the patient’s records. When the pa-
tient was healed or died, the physician’s records were ex-
amined by a local medical council, comprising of other
physicians, in order to decide as to whether the treatment
met the required standards of medical care.
Cancer is a leading cause of mortality, and it strikes more
than one-third of the world’s population and it’s the cause of
morethan20%ofalldeaths[4].Amongthecausesforcancer
aretobaccosmoke,viralinfection,chemicals,radiation,envi-
ronmental factors, and dietary factors. Contemporary physi-
cians and biomedical researchers advocate the need for a
comprehensive cancer treatment including supportive and
palliative care. This patient-centered approach is based, in
part, on the increased awareness of the role of traditional
and complementary medicine in supportive care aimed at
improving patients’ quality of life. This review aims at elu-
cidating Arab and Islamic medicines and their involvement
in approaching issues associated with cancer diagnosis and
treatment, while reviewing the potential role of herbs in
contemporary cancer care.
2.Relevanceof ArabandIslamicMedicineon
CancerCareinthe Middle East
In early 2011, Ben-Arye and his colleagues from six Middle-
Eastern countries identiﬁed 143 articles on complementary
and traditional medicine that had been published in 12
Middle-Eastern countries in relation to cancer care [5]. In
studies performed in Turkey and Israel, about half of the
patients diagnosed with cancer reported use of comple-
mentary and alternative medicine (CAM) [6], even during
chemotherapy treatment [7]. These ﬁndings are comparable
with other reports in the West [8]. Herbal medicine is the
leading modality used by patients with cancer in the Middle
East (e.g., 35% of cancer patients using CAM in Jordan)
[9] along with spiritual practices that are also prevalent
(e.g., 75% of CAM users in Iranian study) [10]. CAM
use is also popular among patients with pediatric [11],
gynecological[12],andhematological[13]malignanciesand
amongpatientswithanadvanceddisease[14].Ben-Aryeand
colleagues reported on 59 articles published in the Middle
East in relation to cancer-related herbal research including
ethnobotanical surveys and reviews (7 articles), in vitro
studies (33 articles), animal studies (8 articles), and clinical
studies (11 articles) [15].
3.CancerinGreco-Araband IslamicMedicine
Roman physicians, for example, Galen (129–199), were al-
readyacquaintedwithtumorsasclinicalentitieswhileadopt-
ing Hippocrates’ (470–370 BC) basic theory of cancer being
an excess of black bile. In the golden Islamic-Arab era,
classic texts, including those of Galen, were translated into
Arabic and thereby inﬂuenced physicians in the Arab-
Islamic world. During the Golden Arab-Islamic civilization
(7th to 14th century), Arab and Muslim physicians studied
cancer and applied various medicines and surgical means
for its treatment. In the medicinal texts of Rhazes, Avicenna,
and Abulcasis, the authors distinguish clearly between the
varieties of cancer types in relation to speciﬁc organs such as,
eye, nasal, tongue, stomach (gastric), liver, bladder, kidney,
testis, breast, spleen, and nerve tumors. Kidney cancer was
ﬁrst mentioned by Al Zahrawi (Abulcasis 936–1013) who
was the ﬁrst to diﬀerentiate between acute inﬂammation of
the kidney and kidney cancer. Both Rhazes and Avicenna
described cancer as a disease which is diﬃcult to treat.
Rhazes, Abulcasis, and Avicenna all realized that the
prospects of curing cancer are prognostically improved if the
cancer is detected at an early stage [16, 17]. Hence, the ﬁrst
goal of treatment would be controlling the tumor’s growth.
They recommended surgical removal if the tumor was small
and accessible, and not close to vital organs. Avicenna
(980–1037), the most inﬂuential of all Islamic philosopher
scientists, suggested “When cancer starts, it may be possible
to keep it as it is, so that it will not increase and keep it non-
ulcerated.Itmayhappensometimesthatthestatingcancermay
b ec u r e d .B u tw h e ni ti sa d v a n c e d ,v e r i l yw i l ln o t ”[ 16, 17].
In his book, Canon,A v i c e n n ad e s c r i b e df o u rw a y st ot r e a t
cancer: (a) total arrest, which was regarded as diﬃcult; (b)
preventing progress; (c) preventing ulceration; (d) treatment
of the ulceration. He empathized that medications per
se would not be of great value since strong medications
increase “cancer evil”. In addition, “one should avoid irritant
medications. And for this, good medications are: pure minerals
like washed pure tutty mixed with oils like rose oil and the
oil of yellow gillyﬂower mixed with it” [16]. Avicenna also
describedoneoftheveryearlysurgicalapproachesforcancer
treatment, as he noted “the excision should be radical and that
all diseased tissue should be removed, which included the use
of amputation or the removal of veins running in the direction
of the tumor ...so that nothing of these will be left”[ 16, 17].
He also recommended the “use of cauterization for the area
being treated if necessary.” One mode of treatment which he
discoveredwasthe“Hindiba”(TheplantChicoriumintybus),
which Ibn al-Baitar later on identiﬁed as having anticancer
properties and which could also be used for other tumors
and neoplastic disorders [2, 18–20]. Avicenna had also stated
that “it (cancer) can be reached by controlling the material,
improving the diet and reinforcing the involved organ by the
known eﬀective medicines, and by using mineral smears like
those containing millstone dust and whet-stone dust and from
smears taken from a mixture between the stone pounder for
aromatics and black head stone moisturized with rose oil and
coriander water...”.
4. Cancer Prevention and Treatment in
Greco-ArabandIslamicMedicine
BasedonrecommendationsofRhazesandAvicenna,patients
in general were treated through a scheme starting with
physiotherapyanddiet;ifthisfailed,drugswereused.Rhazes
treatment scheme started with diet therapy, he noted that “if
the physician is able to treat with foodstuﬀs, not medication,
then he has succeeded. If, however, he must use medications,
then it should be simple remedies and not compound ones”.
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Physicianswereawareoftheinteractionbetweendrugs,thus,
they used simple drugs ﬁrst. If these failed, compound drugs
consisting of two or more compounds were used. If these
conservative measures failed, surgery was undertaken.
4.1.Diet-BasedPreventionandTherapy. Food wasasubstan-
tialpartofpre-Islamicmedicineaswellasinothertraditional
medicines, for example, Greek, Persian, Ayurvedic, and Chi-
nese. Diet is a matter of faith in Islam and plays an important
role in maintaining a healthy body, soul, and spirit. Muslims
are commanded to follow a set of dietary laws outlined in the
Holy Qur’an, where almost everything is permitted, except
whatAllahspeciﬁcallyprohibited.Lateron,whentheIslamic
empire covered all of Arabia, half of Byzantine Asia, all of
Persia, Egypt, the Maghreb (North Africa), and Spain, Arabs
and Muslims not only conquered new lands, but also became
exposed to foreign and multinational culinary heritages.
Great developments in scientiﬁc ﬁelds, the establishment of
“modern” hospitals, and growing socioeconomic conditions
of Islamic empire increased the awareness of the relationship
betweenfoodandhealth.DuringthisperiodatypeofIslamic
food therapy was developed that was a blend of Qur’anic
teaching and Greek medicine.
According to a Hadith (saying) of the Prophet, Peace Be
Upon Him (PBUH) “The stomach is the central basin of the
body, and the veins are connected to it. When the stomach
is healthy, it passes on its condition to veins, and in turn
the veins will circulate the same and when the stomach is
putrescence, the veins will absorb such putrescence and issue
the same”. Indeed, the Prophet used to recommend food for
ailments even more than he prescribed herbs or medicines.
The impact of diet and herbs for the well being of people
was also acknowledged in the Holy Qur’an which mentioned
beneﬁcial eﬀects of several plants and animal products on
nutritional health. Among these are grapes, citrus, melon,
squash, ﬁgs, dates, honey, olive oil, and black seeds. For
example, ﬁgs (Ficus carica) are mentioned by the Prophet
(PBUH) who state that “If I had to mention a fruit that
descended from paradise I would say this is it because the
paradisiacal fruits do not have pits...eat from these fruits for
they prevent hemorrhoids, prevent piles and help gout.” [21].
Indeed, ethnobotanical research suggests that ﬁgs are used to
treatmalignantandinﬂammatorydiseases[22].TheProphet
(PBUH) also recommended the use of olive oil, by stating
“Eat olive oil and massage it over your bodies since it is a holy
(Mubarak) tree”. Dates were mentioned in twenty places in
the Qur’an, as the Prophet (PBUH) was reported to have
said: “if anyone of you is fasting, let him break his fast with
dates. In case he does not have them, then with water. Verily
water is a puriﬁer” [21].
Greco-Arab and Islamic scholars, such as Avicenna,
Rhazes, and Abulcasis discussed the eﬀect of diet on cancer
development and progression. While alluding to cancer pre-
vention Avicenna quoted “As to preventing its (cancer)
progress, it can be achieved by ...improving the diet and rein-
forcing the involved organ by the known eﬀective medications.”
This ancient attribution of the role of nutrition in cancer
has been acknowledged extensively in the scientiﬁc literature
involving carcinogenesis [23] and the interrelation between
cancer incidence and recurrence and nutrition and lifestyle
(e.g., obesity as a cancer risk factor [24, 25]).
4.2. Mediterranean Diet. During the last half century, epi-
demiological studies have consistently shown that there are
clear signiﬁcant positive associations between intake of fruits
and vegetables and reduced rate of heart diseases mortality,
common cancers, and other degenerative diseases as well as
ageing. This is attributed to the fact that these foods may
provide an optimal mix of dietary ﬁber, natural antioxidants,
and other biotic compounds. Various substances in the
food can control the physiological functions of the body
and modulating immune responses. Immune functions are
indispensable for defending the body against attack by
pathogens or cancer cells and thus play a pivotal role in the
maintenance of health. However, the immune functions are
disturbed by malnutrition, aging, physical and mental stress,
or undesirable lifestyle. Therefore, the ingestion of foods
withimmune-modulating activities isconsideredan eﬃcient
way to prevent immune functions from declining and reduce
the risk of infection or cancer.
Traditional Mediterranean diet includes a signiﬁcantly
large amount and variety of plant foods, for example,
fruits, vegetables, wild edible plants, breads, seeds, nuts,
and olive oil. Therefore, it guarantees an adequate intake of
carotenoids,vitaminC,tocopherols,α-linolenicacid,various
important minerals, and several possibly beneﬁcial nonnu-
trient substances such as polyphenols and anthocyanins and
dietary ﬁber [26, 27].
4.3. Edible Wild Plants. Wild edible plants are commonly
consumed in the eastern region of the Mediterranean. Wild
edible herbs have always been a main part of traditional diets
and were known for their health qualities among local com-
munities and indigenous people long before their nutritious,
protective, and therapeutic eﬀects were proved by scientiﬁc
research. A high percentage of individuals collect wild edible
plants and consume them as part of traditional food habits.
Traditional food habits have been characterized by dietary
diversityandhavebeenassociatedwithlowhealthrisks.Wild
edible plants have been identiﬁed as main components of
these diets and as important contributors to their health-
protective properties. Many wild species are collected from
the surrounding environment and consumed as part of local
diets, especially in times of shortage. Various wild greens
contain high nutritional values with relatively low energy.
Compared with commonly eaten vegetables, they provide
the diet with greater amounts of minerals. Additionally,
their antioxidant property, mainly from phytochemicals, was
found to be two to three times higher than that of common
vegetables [26].
4.4. Herbal-Based Prevention and Therapy. There is com-
pelling evidence from epidemiological and experimental
studies that highlight the importance of phytochemicals
isolated from traditional medicinal plants to prevent/reduce
sometypesofcancerandinhibitthedevelopmentandspread
of tumors in test animals. The term phytochemical refers to
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Table 1: Eﬀects of food and herbal-derived compounds in cancer chemoprevention.
Active principle(s) Sources Apoptosis
induction
Anti
angiogenesis
Anti
metastasis eﬀect
Anti
inﬂammatory/
Antioxidant
properties
References
Citral
Aloysia citrodora Palau,
Cymbopogon sp. Melissa
oﬃcinalis L.
+ [43]
Crocetin Crocus sativus L. ++++ [44, 45]
Curcumin Curcuma longa L. ++ + [46, 47]
Diallyl sulﬁde Allium sativum L. ++ + [48, 49]
Fibers, Lignans,
isoﬂavones, and
phenolic acids
Triticum aestivum L. + [50–52]
Several ﬂavonoids Ficus carica L. ++ [53, 54]
Inulin-type fructans
beta(2,1) fructans Cichorium intybus L. +++ [55]
Oleuropein Olea europea L. ++++ [39, 40, 56]
Several polyphenols Punica granatum L. ++++ [57, 58]
Quercetin Allium cepa L. ++ + [59, 60]
Silymarin Silybum marianum L.
Gaertn. ++ + [61–63]
Thymoquinone Nigella sativa L. ++++ [64–66]
Several active
compounds Arum palaestinum L. ++ [2, 30, 67]
Several active
compounds Honey ++ [68–70]
this term is usually applied to nutritive and nonnutritive
compounds that occur naturally in fruits and vegetables.
More than 25% of drugs used during the last 20 years
are directly derived from plants, while the other 25% are
chemically altered natural products. Still, only 5–15% of the
approximately 260,000 higher plants have ever been investi-
gated for bioactive compounds. The advantage of using such
compounds for cancer treatment is their relatively low/non-
toxic nature [28, 29]. An ideal phytochemical is one that
possesses antitumor properties with minimal side eﬀects and
has a deﬁned mechanism of action. Some phytochemicals
are likely to possess anticancer eﬀects (Table 1). According to
recentsurveys,manycancerpatientsusecomplementaryand
alternative medicines, including phytochemicals in addition
to, or following the failure of standard cancer therapy. A
diet rich in fruits and vegetables has long been suggested to
correlate with reduced risk of certain epithelial malignancies,
including cancers in the lung, colon, prostate, oral cavity,
and breast [28, 30]. Also, the cancer prevention potential
of Mediterranean diets based mainly on olive tree products
is known. As discussed below, the major active ingredient
of the leaves and oil of Olea europaea is oleuropein and
the majority of polyphenols found in olive oil or table
olives are derived from its hydrolysis. Oleuropein is a
novel, naturally occurring antioxidant compound, which
may possibly be used to prevent cancer and cardiotoxicity
induced by doxorubicin. Searching for medicinal beneﬁts
from edible or inedible plants is not a novel idea since
numerous modern medicines have plant origins. Given that
the ingestion of some plant foods results in reduced risk
for cancer, researchers are delving into the identiﬁcation
of phytochemicals with cancer preventive ability in studies
in vitro, in vivo, and those in humans. Phytochemicals
can be roughly classiﬁed into four groups based on their
mechanisms of chemopreventive and therapeutic properties,
as shown in Table 1.
In the following paragraphs, we will focus on nine widely
used herbs that are commonly used in the context of cancer
by patients in the Middle East: Olive, black seeds, saﬀron,
pomegranate, nettle, Garlic, onion, Palestinian arum, and
grapes [2, 3, 5, 31–33]. Other commonly used medicinal
plants and wild edible plants are described in Table 1 and
[30].
4.5. Olea Europea (Olive). O. europaea (the olive) is a species
of the family Oleaceae. The olive tree is an evergreen tree or
shrub native to the Mediterranean, Asia, and the Maghreb
region. Olive leaf and olive leaf extracts are now marketed
as antioxidants, antiaging, immunostimulators, and even
antibiotics. Clinical evidence has proven the antidiabetes
and antihypertension eﬀects of leaf extracts. In addition,
several studies support its antibacterial, antifungal, and anti-
inﬂammatory properties [34–36].
Epidemiological studies provide convincing evidence
for a protective eﬀect of the Mediterranean diet against
cardiovascular disease and cancer [37, 38]. These ﬁndingsEvidence-Based Complementary and Alternative Medicine 5
prompted scientists to search for Mediterranean ﬂora as
a rich source of bioactive phytochemicals with a potential
to evolve into preventive and possibly therapeutic agents.
Much epidemiological evidence suggests that people who
consume an olive oil rich diet have a lower incidence of
certain cancers, including breast, skin, and colon [34]. The
lower incidence of certain cancers is most likely associated
with the antioxidant activity of active ingredients of the
olive oil. Oxidative stress has been shown to contribute to
cancer development, and antioxidants are believed to reduce
the risk of mutagenesis and carcinogenesis. Hydroxytyrosol
was found to be capable of protecting cells from hydrogen
peroxide damage and DNA from peroxynitrite-induced
damage, blocking cell cycle progression at the G1 phase,
and inducing apoptosis [39]. In vivo and in vitro studies
on the activity of oleuropein have found that, in addition
to antioxidant properties, it has antiangiogenic action and
inhibits cell growth, motility, and invasiveness. Oleuropein
was also found to cause cell rounding, which disrupts the
cell actin cytoskeleton. Oleuropein also aﬀects and disrupts
puriﬁed actin ﬁlaments, providing direct antitumor eﬀects
due to cell disruption. In in vivo animal studies, rapid
tumor regression was observed when mice were given one
percent oleuropein in drinking water [40]. Saturated animal
fats and polyunsaturated plant fats in the diet have been
implicated in colon, breast, prostate, and ovarian cancers.
The vast usage of olive oil in the Mediterranean diet may
explain its apparent cancer-protective eﬀect, rather than the
amount of fat consumed. Furthermore, in a recent study
evaluating the antioxidant and antiproliferative activity of
water and methanol olive leaves extracts in cancer and
endothelial cells, olive leaf crude extracts were found to
inhibit proliferation of cell from a human breast adenocar-
cinoma, cells from human urinary bladder carcinoma (T-
24),andcellsfrombovinebraincapillaryendothelial(BBCE)
[39, 41, 42].
4.6. Nigella Sativa (Black Seeds). N. sativa of the Ranuncu-
laceae family is one of the most commonly used medicinal
plants throughout the Middle East. N. sativa seeds have
been used for centuries as a spice and food preservative,
as well as a protective and curative remedy for numerous
diseases. The seeds are known to have many medicinal
properties and are widely used in Greco-Arab and Islamic
medicine. The plant is found wild in North Africa, the
Mediterranean region, Asia Minor, and in Southern Europe.
N. sativa is one the most referenced medicinal seeds in
history. In many civilizations the herbal spice N. sativa was
referred to as Habbat-el-barakah (literally seeds of blessing
in Arabic), Kalonji (Hindi), Kezah (Hebrew), Sijah Daneh
(Persian) and Black Caraway in English. The famous Greek
physician dioscorides [40–42, 44, 45, 57, 59, 71–114] used
blackseedstotreatheadachesandtoothaches.N. sativa seeds
and oil extracts have been widely used for centuries to treat
disorders in the respiratory system, stomach, kidney and
liver function, and circulatory, immune system as well as
cancer. In Islam, it was regarded as one of the greatest forms
of healing medicine available [71]. Prophet Mohammad
(PBUH) stated “The black seed can heal every disease, except
death” [21]. Avicenna referred to black seed in his “Canon
of Medicine” as the seed that stimulates the body’s energy
and helps recovery from fatigue and dispiritedness. In the
Unani Tibb system which is still practiced in central Asia
and India seeds are regarded as a valuable remedy for a
number of diseases. The seed’s oil was used to treat skin
conditions such as eczema and burns and to treat cold
symptoms.
Modern research studies showed that N. sativa seeds
ethanolextractpossessesantitumoractivityinmiceimplant-
ed with tumor primary cells [72]. N. sativa seed extracts
contain amino acids, proteins, carbohydrates, alkaloids,
saponins, ﬁxed, and volatile oils.
Thymoquinone has been found to be the main com-
pound responsible for the pharmacological properties of
the volatile oil of N. sativa. The biological activities and
therapeutic potential of thymoquinone are discussed in
details by Salem [73]. In brief, thymoquinone was found to
possess potent anticancer and antioxidant abilities in animal
models and cell culture systems. It acts as an antioxidant and
inhibited iron-dependent microsomal lipid peroxidation,
cardiotoxicity induced by doxorubin in rats, and inhibited
ifosfamide-induced damage in kidney. It also prevented liver
injury induced with carbon tetrachloride, lowered drug-
induced toxicity and causes amelioration in the drug’s
anticancer activity. There are studies reporting that the
anticancer potential of thymoquinone is related to its pro-
oxidant activities. In human colon cancer cell cultures and
in isolated rat liver mitochondria, thymoquinone induced a
signiﬁcant release of reactive oxygen species and inhibited
the activity of aconitase, an enzyme sensitive to superoxide
anion generation. One of the most promising eﬀects of
thymoquinone is its high cancer speciﬁcity and low toxicity
to normal cells. This has been observed in prostate cancer,
colon cancer, canine osteosarcoma, and skin cancer [74, 75].
Many multi-drug-resistant variants of human pancreatic
adenocarcinoma, uterine sarcoma, and leukemia were found
to be sensitive to thymoquinone [76]. These ﬁndings pro-
vide further support to the great potential of developing
synthetic derivatives of thymoquinone as anticancer agents.
Thymoquinone induces apoptosis through modulation of
multiple targets and hence is a promising phytochemical
agent that could be used for killing many types of cancer
cells, such as prostate cancer cells. Thymoquinone blocked
angiogenesis in vivo, prevented tumor angiogenesis in a
xenograft human prostate cancer model in mouse, and
inhibited human prostate tumor growth with almost no
side eﬀects. In vivo, thymoquinone inhibited the growth of
prostate and colon tumors implanted in nude mice with no
noticeablesideeﬀects.Incolonxenografts,growthinhibition
by thymoquinone was not due to decreased proliferation but
rather to the signiﬁcant induction of apoptosis. However,
in androgen-independent prostate tumor xenografts, the
suppression of tumor growth was associated with a massive
apoptosis [77]. These results indicate that the antitumor
activity or cell growth inhibition could in part be due to the
eﬀect of thymoquinone on cell cycle [75].
Although N. sativa seeds and oil are recognized safe,
only a few studies have addressed its potential toxicity. In6 Evidence-Based Complementary and Alternative Medicine
one study, serum gamma-glutamyl transferase and alanine
aminotransferaseconcentrationsweresigniﬁcantlyincreased
after water extracted black seeds were administered orally to
rats for 14 days. However, no evident pathological changes
were reported [78]. Black seeds oil toxicity was tested in
another study in mice and rats through examination of
possible biochemical, hematological, and histopathological
changes. LD50 was 28.8mL/kg body for single (acute)
oral determination dose and 2.06mL/kg for intraperitoneal
administration [79].
Chronic toxicity was studied in rats treated with an oral
doseof2mL/kgdailyfor12weeks.Nochangeswerereported
neither in key hepatic enzymes levels (i.e., ALT, AST, and
GSH), nor in histopathological modiﬁcations (heart, liver,
kidneys, and pancreas). Nevertheless, serum cholesterol,
t r i g l y c e r i d e ,a n dg l u c o s el e v e l sa sw e l la st h ec o u n to f
leukocytes and platelets decreased signiﬁcantly and slowing
of body weight gain was reported. Some other studies had
reported black seeds and thymoquinone toxicity in rats and
mice when exposed to high doses [79–81]. Taken together, a
degree of caution is necessary with larger amounts of Nigella
sativa due to the presence of thymoquinone and other active
ingredients.
4.7. Crocus Sativus (Saﬀron). Saﬀron has a long history as
part of traditional healing. Modern medicine has also dis-
covered saﬀron as having anticarcinogenic, antimutagenic,
immunomodulating, and antioxodant-like properties [82].
Saﬀroncontainsseveralactivecompoundsincluding,butnot
limited to, ﬂavonoids, tannins, carotenoids, anthocyanins,
alkaloids, and saponins. A number of in vitro and in vivo
studies have reported an antitumor properties of saﬀron
[44, 82–85]. Pretreatment with saﬀron prevented oxidative
stressinducedbyDMBA(7,12-dimethylbenz[α]anthracene),
known to generate DNA-reactive species and skin carcinoma
in mice [83]. These eﬀects are contributed to an active com-
pound, crocetin [86, 87], that exhibited antitumor activity
in a lung cancer animal model by scavenging free radicals
and drug metabolizing enzymes [88]. It also inhibited
pancreatic cancer cell proliferation and tumor progression
in a xenograft mouse model and downregulated growth and
proliferation stimulated apoptosis and resulted in signiﬁcant
growth regression in pancreatic tumors. However, it is
not known whether the eﬀe c to fc r o c e t i no np a n c r e a t i c
cancer regression is its own receptor-dependent or receptor-
independent mechanisms [89].
Crocetins antitumor activity was evaluated in several
cancer cell lines [86, 87]. For instance, crocetin inhibited
MCF-7 and MDA-MB-231 breast cancer cell lines prolifer-
ation [82, 84, 90] via downregulation of matrix metallopro-
teinases [45]. Crocetin and carotenoids, in general, showed
cytotoxic eﬀects on a range of tumors and malignant cells
[82]. It had interfered with DNA transcription as well as
DNA, RNA, and protein synthesis through suppression of
the activity of DNA-dependent RNA polymerase II [44].
Crocetins LD50 is relatively high (2g/kg) [82, 84, 90] raising
the possibility that it could be relatively nontoxic with a
potential to exert an antitumor eﬀect.
4.8. Punica Granatum (Pomegranate). Pomegranates have
been used for a long time in traditional Greco-Arab and
Islamic medicine for the treatment of a variety of ailments,
including sort throat, inﬂammation, and rheumatism. It was
also used for treating bladder disturbances, strengthening
gums, and soothing mouth ulcers. Pomegranates feature
prominently in all religions: Islam, Judaism, Christianity,
Buddhism, and Zoroastrianism. According to the Qur’an
pomegranates grow in the gardens of paradise. Among the
small number of fruits and vegetables mentioned in the
Qur’an, (including date, olive, grape, banana, ﬁg, cucumber,
garlic, lentil, and onion), pomegranate was mentioned three
times, indicating its signiﬁcance in Muslims life. This fruit
was consumed as fresh or in the form of juice. Pomegranate
is known as an antioxidant agent and is used to treat several
diseases including cancer, inﬂammation, cardiovascular dis-
ease, diabetes, bacterial infections and antibiotic resistance,
and ultraviolet radiation-induced skin damage [91–93]. Yet,
for the most part, research is focused on its antioxidant, anti-
inﬂammatory, and anticarcinogenic properties.
4.9. Pomegranate Juice. Pomegranate Juice is a rich source
of antioxidant tannins, ﬂavonoids (quercetin), and some
other antitumor compounds. Recent research has shown
that pomegranate juice selectively inhibited the growth of
breast, colon, and lung cancer cells in culture, decreased
proliferation and induced apoptosis of DU-145 prostate
cancer cells and suppressed invasive potential of PC-3 cells.
These eﬀects may be associated with the plant-based anti-
inﬂammatory eﬀects [94, 95]. Pomegranate juice was also
eﬀective in inhibition of inﬂammatory cell signaling in colon
cancer [96]. In preclinical animal studies, oral consumption
of pomegranate extract inhibited growth of lung, skin,
colon, and prostate tumors [95, 96]. Pomegranate fruit
extract was also eﬀective in inhibition of lung tumori-
genesis in mice [97]. Thus, pomegranates consumption
could potentially help in reducing the growth and spread
of prostate and lung cancer cells or even prevent cancer
from developing. Pomegranate juice has also shown an
initial promise in a phase II clinical trial against prostate
cancer [98]. Pomegranate juice given to men with rising
prostatespeciﬁcantigen(PSA)followingsurgeryorradiation
oﬀered positive and beneﬁcially signiﬁcant eﬀects on PSA
parameters, suggesting a potential of pomegranate-derived
products for prevention of human prostate cancer [91].
4.10.PomegranateSeeds. Upto20%ofthepomegranateseed
weight is oil especially fatty acids (manly is triacylglycerols)
[99]. Pomegranate seeds matrix includes also lignines and
some of its derivates possess antioxidant activity [100]. The
seeds oil had beneﬁcial outcome in inﬂammation downreg-
ulation and thus cancer preventive eﬀects. For instance, it
had inhibited PC-3 prostate cancer cell line phospholipase
A2 expression [94] and upregulated MAPK-APK2 in DU-
145 prostate cancer cells [57]. In mouse model, 1μg/mL
seed oil suppressed tumor occurrence almost completely
in mammary organ culture [101] and colon carcinogenesis
inducedbyazoxymethane[102].Externaltreatmentwith5%
seeds oil produced signiﬁcant decreases in mouse skin tumorEvidence-Based Complementary and Alternative Medicine 7
incidence and multiplicity [103]. The oil also downregulated
proangiogenic vascular endothelial growth factor (VEGF) in
MCF-7 breast cancer cells and induced apoptosis in human
breast cancer cells [104].
4.11. Pomegranate Peel. Traditionally, pomegranate peels are
dried, decocted in water, and employed both internally and
externally to heal aphthae and diarrhea. Pomegranate peel
has been shown to possess anticancer activities, including
interferencewithtumorcellproliferation,cellcycle,invasion,
and angiogenesis [101]. Pomegranate peel extract delays the
proliferation of human breast and prostate cancer cell lines
[105]. Pomegranate peel and juice contain several active
compounds(i.e.,catechins,epicatechins,proanthocyanidins,
anthocyanidins, quercetin) known to be principal for cell
cycle arrest, proliferation prevention, and apoptosis initia-
tion [106].
More speciﬁcally, catechins and epicatechins possess an-
tiangiogenic, antioxidant, and anticarcinogenic activities
[107]. They also inhibited cyclooxygenase activity, nitric
oxide production, and the epidermal growth factor receptor
[108].
Quercetin is well known for its anticancer activity. It
had inhibited lung cancer cell growth via cell cycle arrest
and apoptosis induction [109]. More recently, Park and Min
showed that quercetin induces downregulation of phospho-
lipase D1 and thus inhibited proliferation and invasion in
glioma (U87) cells [110]. Quercetin anticancer beneﬁcial
eﬀects were also evaluated in animal models [111] and in
clinical trials [59]. The anticarcinogenic eﬀects of the other
isolated fractions and compounds of the pomegranate were
described elsewhere [92, 112].
4.12. Urtica Dioica (Nettle). The origin of its Latin name,
Urtica, means “I burn”, indicative of the stings caused by
glandular hairs on the leaves that contain formic acid and
histamine, two agents known to cause the stinging and skin
irritation after contact. U. dioica leaf has a long history as
an herbal remedy and nutritious addition to the diet. Nettle
leaves are a rich source of essential amino acids, ascorbic
acid, several mineral element, and vitamins, such as iron,
provitamin A, and vitamin C [113]. Nettle extracts can be
used to treat arthritis, hay fever, kidney problems, pain, and
anemia. Nettle extracts possess hypoglycaemic properties
andimproveglucosetolerance[35].U.dioicaisbelievedtobe
antioxidant, immunesuppressive, antirheumatoid, antiulcer,
anti-inﬂammatory,andanticarcinogenic[14].Indeed,itsleaf
[114]a n dr o o t s[ 115]e x t r a c t sw e r ee ﬀective against prostate
cancer proliferation.
4.13. Allium Sativum L. and Allium Cepa (Garlic and Onion).
ProphetMohammad(PBUH)said“althoughonionandgarlic
have a bad smell, they are cures for 70 diﬀerent illnesses that
cannot be cured by any other means”. Onion (A. cepa)a n d
garlic (A. sativa) are closely related vegetables that belong to
the Allium class of bulb-shaped plants, which also includes
chives, leeks, and scallions. Garlic is used for ﬂavoring in
cooking and is unique due to its high sulfur content, along
with arginine, oligosaccharides, ﬂavonoids, and selenium, all
of which might promote health [116].
The association between the consumption of Allium
vegetables and the risk for cancer was assessed in several
epidemiologic studies, showing the protective eﬀect of garlic
and onion on cancer. In China, high consumption of Allium
vegetables was associated with lower incidence of gastric
cancer [117, 118]. Additional studies in the Netherlands sug-
gested an inverse correlation between the risk of colorectal,
breast, and lung cancers and the consumption of onion and
garlic [119].
Steinmetz et al. [120] studied the association between
garlic consumption and the risk of colon cancer and found
that women who consumed high amounts of garlic had a 50
percentlowerincidenceofdistalcoloncancercomparedwith
women who consumed less garlic [120]. The risk of breast
cancer was also found to be reduced in women consuming
greater amounts of ﬁber garlic and onions [31], as well
as that of esophageal and stomach cancers [121]. Similar
ﬁndings were noted with reference to the risk of prostate
cancer [122, 123], pancreatic cancer [33], and other known
cancer types [124]. The amount of garlic consumed in
the above studies varied from 2 to 20g daily (The World
Health Organization (WHO) guidelines for general health
promotion for adults recommend a daily dose of 2 to 5g
of fresh garlic). It was noted that although garlic had been
used safely in cooking, excessive consumption can cause
some side eﬀects, in addition to those of strong breath and
body odors [125] .T h ep r o t e c t i v ee ﬀect of Allium vegetables
against tumor progression and against angiogenesis were
attributed to its organosulfur compounds especially allicin
(an active compound in garlic) and diallyl disulﬁde [126].
Such compounds are able to block the formation of cancer-
causing substances [127], halt the activation of cancer-
causing substances [128, 129], enhance DNA repair [130],
reduce cell proliferation, or induce apoptosis-programmed
cell death (Table 1 and [126, 131]).
T h ep r o t e c t i v ee ﬀects of onion and garlic organosulfur
compounds against carcinogenesis were also studied in
animal models and in vitro. When administrating the above
compoundstomice2–4dayspriortoacarcinogenchallenge,
these compounds inhibited the development of pulmonary
adenoma [132]. Intravenous administration of the garlic
activecompound(diallyltrisulﬁde)signiﬁcantlyretardedthe
growth of orthotopically transplanted hepatoma in BALB/c
nude mice [133]. These compounds had also halted the
proliferation of cancer cell lines, including human lung,
skin and colon tumor cell lines, human neuroblastoma cells,
human and murine melanoma cells, and human prostatic
carcinoma cells [134–137].
4.14. Arum Palaestinum (Palestinian Arum). Arum is edible
plant and is widely used in the Middle-East cooking,
especially in the Palestinian kitchen. According to a survey
conducted in 2008, Palestinian Arum was found to be one
of the most potent anticancerous (especially colon cancer)
plant in Palestine [3]. Moreover, A. palaestinum is also
eﬀective against internal bacterial infections, poisoning, and
disturbances of the circulatory system. Care should be taken8 Evidence-Based Complementary and Alternative Medicine
especially when using A. palaestinum to treat tumor since
it may cause negative side eﬀects. For instance, ﬂavonoid
isoorientin (6-C glucoside of luteolin), isolated from A.
palaestinum possesses myolytic activity on rat and guinea
pig smooth muscle [138]. However, the action mechanism
of Palestinian Arum awaits further studies.
4.15.VitisVinifera(Grapes). Grapesexertseveralhealthben-
eﬁts, including, but not limited to, anti-inﬂammatory and
anticancer eﬀects and prevent lipid oxidation and platelet
aggregation. The main active compound in grapes is the
polyphenol compound resveratrol. Resveratrol is believed
to decrease circulating LDL (low-density lipoprotein) and
cholesterolandthusreducetheriskofcardiovasculardiseases
[139]. Grapes, as many other fruits and vegetables, are
rich in antioxidant compounds called ﬂavonoids. They are
among the plant chemicals that have shown a potential
beneﬁt against heart disease. Flavanoids as well as the
whole black grape (including seeds) were shown to inhibit
key enzymes in tumor cell, thereby inducing apoptosis
and or blocking their growth [140, 141]. In rats, grape
seeds extracts (proanthocyanidins) reduced the progress of
ulcerative colitis thereby decreasing the risk of colorectal
cancer [142].
5. Discussion
During the Arab-Islamic Golden Age, collaborative works of
physicians and scientists from diﬀerent nations and ethnic
groups raised the dignity and caliber of the medical profes-
sion. Disease was seen by Arabs and Muslim physicians as a
problem that can be challenged. The Prophet (PBUH) was
credited with many statements on health care problems and
their treatments. For instance,“ T h eo n ew h os e n td o w nt h e
disease sent down the remedy.” and “For every disease, God has
given a cure.” He was also credited with articulating several
speciﬁc medical treatments, including the use of honey, olive
oil, ﬁgs, and cupping. Regarding cancer, Avicenna, Rhazes,
and Al-Zahrawi have inﬂuenced the ﬁeld of oncology, by
establishing clinical approach and therapeutic means (i.e.,
surgery) which inspired medical research for ﬁve centuries.
Contemporary research supports the potential of herbs used
in Islamic medicine for patients with cancer. More research
is warranted regarding the potential beneﬁt of traditional
Islamic herbs in alleviation of chemotherapy side eﬀects
and improved patients’ quality of life. This line of research
may bridge past wisdom with present needs and future
perspectives, thus fostering comprehensive cancer treatment
attuned to the social and religious concerns of patients
allover the Middle-East.
Despite the rapidly increasing understanding of the mo-
lecular and cellular processes, the morbidity of cancer is
still on the rise. Cancer epidemiology has revealed that
certain cancers are more common among people of diﬀerent
cultures and ethnicities, such as cancer of the lung, colon,
prostate, and breast, which are very common in western
societies, while they are not as prevalent in eastern societies.
The prevalence of cancer in the developing countries is
increasing, and the global burden of cancer is estimated
to approximately double between 2008 and 2030 from
12.4 million new cases per year to around 26.4 million. A
majority of this increase will occur in developing countries
where the health services are least able to cope with the
challenge. This inequality is highlighted by the markedly
lower cancer survival rates in these regions (including Arab-
Islamic countries) [143], and the best way to treat cancer is
by preventing it and diagnosing it at earlier stages.
Pastmedicalliteratureisavaluablesourceofinformation
which entails potential research topics for contemporary
scientiﬁc work. Several studies have already referred to the
biological activities of natural products such as stimulation
of the immune system, antibacterial, antiviral, antihepato-
toxic, antiulcer, anti-inﬂammatory, antioxidant, antimuta-
genic, and anticancer eﬀects [2, 125, 144–146]. A variety
of grains, cereals, nuts, soy products, olives, beverages such
as tea and coﬀee, and spices including turmeric, garlic,
ginger, black pepper, cumin and caraway confer a protective
eﬀect against cancer [31, 33, 125, 145, 147]. Several studies
have also documented the relationship between decreased
cancer risk and high consumption of vegetables, including
cabbage, cauliﬂower, broccoli, brussels sprout, tomatoes,
and fruits such as, apples and grapes [2, 33, 146, 148].
In addition, a number of medicinal plants and herbs have
also been reported to reduce the risk of cancer in multiple
sites (Table 1 and [149, 150]). With regard to anticancer
drugs, various currently used drugs are the derivatives
of plant sources including, but not limited to, paclitaxel
(taxol), vinblastine, capsaicin, vincristine, the camptothecin
derivatives, topotecan, irinotecan, and etoposide (Table 1
and [146, 151–153]). Many commonly used anticancer
herbs possess chemopreventive eﬀects within their diverse
pharmacological properties. Since cancer evolves over a long
period of time, agents that inhibit or retard one or more
of its stages could aﬀect the overall course of the disease.
Certain micronutrients (like oleuropein and diallyl sulﬁde
compounds found in olives and garlic, resp.) possess potent
cancer-preventive capacities.
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